Correlation Between Bank of America and Oramed Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Bank of America and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Oramed Pharmaceuticals.

Diversification Opportunities for Bank of America and Oramed Pharmaceuticals

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bank and Oramed is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Bank of America i.e., Bank of America and Oramed Pharmaceuticals go up and down completely randomly.

Pair Corralation between Bank of America and Oramed Pharmaceuticals

Considering the 90-day investment horizon Bank of America is expected to generate 0.29 times more return on investment than Oramed Pharmaceuticals. However, Bank of America is 3.42 times less risky than Oramed Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  3,278  in Bank of America on August 26, 2024 and sell it today you would earn a total of  1,422  from holding Bank of America or generate 43.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bank of America  vs.  Oramed Pharmaceuticals

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
Oramed Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oramed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Oramed Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Bank of America and Oramed Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and Oramed Pharmaceuticals

The main advantage of trading using opposite Bank of America and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.
The idea behind Bank of America and Oramed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets